mbp have taken a hiding in the past week, while I'm sure their drugs ok, the markets certainly worried, but still give them a market cap of $300 mil.
ept on the other hand are quietly putting the finishing touches on their strategy to take melanontan to commercialization, with a market cap of only $100 mil. and a potential $7 bil + p.a. market to tap into the share price looks cheap.
Certainly some interesting leverage to be had with ept if all goes to plan, 2005 should be it imho.
to your own research
cheers, stainless
mbp have taken a hiding in the past week, while I'm sure their...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.96 |
Change
-0.190(1.25%) |
Mkt cap ! $749.5M | |||
| Open | High | Low | Value | Volume |
| $14.99 | $15.03 | $14.87 | $607.7K | 40.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40 | $14.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 61 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |